Nässberger L
Department of Medical Microbiology, Lund University, Sweden.
J Biolumin Chemilumin. 1993 Jan-Feb;8(1):33-7. doi: 10.1002/bio.1170080107.
We investigated interaction between antibodies directed against myeloperoxidase (anti-MPO) and myeloperoxidase (MPO) with chemiluminescence. Whole serum diluted 1/10 containing circulating anti-MPO antibodies as well as serum from normal blood donors inhibited myeloperoxidase (MPO) enzyme activity when incubated with 1.42 micrograms MPO. When further diluted the inhibitory effect was abolished. Incubation with purified human IgG fraction of anti-MPO, did not cause any inhibition when diluted 1/10 and incubated with 1.42 micrograms MPO. When adding MPO to normal sera a rapid increase of the enzyme activity was seen above 5 micrograms, and the inhibitory effect was completely abolished when 10 micrograms was added. Both sera from healthy individuals, as well as sera from patients with circulating anti-MPO inhibited MPO activity. The inability of pure IgG fractions from anti-MPO sera to inhibit MPO enzyme activity, clearly indicates the presence of an inhibitory factor, unspecific or specific, in serum.
我们用化学发光法研究了抗髓过氧化物酶抗体(抗MPO)与髓过氧化物酶(MPO)之间的相互作用。含有循环抗MPO抗体的稀释1/10的全血清以及正常献血者的血清,在与1.42微克MPO孵育时会抑制髓过氧化物酶(MPO)的酶活性。进一步稀释后,抑制作用消失。用抗MPO的纯化人IgG组分进行孵育,当稀释1/10并与1.42微克MPO孵育时,未产生任何抑制作用。向正常血清中加入MPO时,在5微克以上酶活性迅速增加,加入10微克时抑制作用完全消失。健康个体的血清以及有循环抗MPO的患者血清均抑制MPO活性。抗MPO血清的纯IgG组分无法抑制MPO酶活性,这清楚地表明血清中存在一种抑制因子,无论是非特异性的还是特异性的。